Covid-19 and Force Majeure in Light of Vietnamese Law and Pharmaceutical Practice

The business operation has been slowing down since the start of the diseases initially detected and spread in Wuhan, China.

In Vietnam, the Government has adopted strong measures with the aim to contain the spread and the pandemic.

However, such actions have raised a number of issues on how Pharma MNCs can fulfil their contractual obligations, especially in drug import and tender as approximately 80% of Vietnam’s drug consumption market is originated from the most Covid-19 affected countries in the world (e.g., the USA, Italy, France, Japan, etc.).

This Covid-19 Newsletter Update addresses whether the Covid-19 pandemic may constitute a Force Majeure Event under Vietnamese law, with a specific focus on the Pharmaceutical Industry.